Weight-Loss Drug Giant Eli Lilly Bets Big Again. Spending $7.8 Billion to Acquire Centessa, Is Now a Good Time to Buy Eli Lilly?
TradingKey – March 31, ET, Eli Lilly (LLY.US) officially announced that it will acquire the U.S.-listed company for a total consideration of $7.8 billion Centessa Pharmaceuticals (CNTA.US) , with the transaction expected to close in the third quarter of 2026. Following the news, Eli Lilly shares rose approximately 3% on Tuesday, while Centessa shares surged…
